Abstract:As the great majority of gene expression (GE) biodosimetry studies have been performed using blood as the preferred source of tissue, searching for simple and less-invasive sampling methods is important when considering biodosimetry approaches. Knowing that whole saliva contains an ultrafiltrate of blood and white blood cells, it is expected that the findings in blood can also be found in saliva. This human in vivo study aims to examine radiation-induced GE changes in saliva for biodosimetry purposes and to predict radiation-induced disease, which is yet poorly characterized. Furthermore, we examined whether transcriptional biomarkers in blood can also be found equivalently in saliva. Saliva and blood samples were collected in parallel from radiotherapy (RT) treated patients who suffered from head and neck cancer (n = 8) undergoing fractioned partial-body irradiations (1.8 Gy/fraction and 50–70 Gy total dose). Samples were taken 12–24 h before first irradiation and ideally 24 and 48 h, as well as 5 weeks after radiotherapy onset. Due to the low quality and quantity of isolated RNA samples from one patient, they had to be excluded from further analysis, leaving a total of 24 saliva and 24 blood samples from 7 patients eligible for analysis. Using qRT-PCR, 18S rRNA and 16S rRNA (the ratio being a surrogate for the relative human RNA/bacterial burden), four housekeeping genes and nine mRNAs previously identified as radiation responsive in blood-based studies were detected. Significant GE associations with absorbed dose were found for five genes and after the 2nd radiotherapy fraction, shown by, e.g., the increase of CDKN1A (2.0 fold, P = 0.017) and FDXR (1.9 fold increased, P = 0.002). After the 25th radiotherapy fraction, however, all four genes (FDXR, DDB2, POU2AF1, WNT3) predicting ARS (acute radiation syndrome) severity, as well as further genes (including CCNG1 [median-fold change (FC) = 0.3, P = 0.013], and GADD45A (median-FC = 0.3, P = 0.031)) appeared significantly downregulated (FC = 0.3, P = 0.01–0.03). A significant association of CCNG1, POU2AF1, HPRT1, and WNT3 (P = 0.006-0.04) with acute or late radiotoxicity could be shown before the onset of these clinical outcomes. In an established set of four genes predicting acute health effects in blood, the response in saliva samples was similar to the expected up- (FDXR, DDB2) or downregulation (POU2AF1, WNT3) in blood for up to 71% of the measurements. Comparing GE responses (PHPT1, CCNG1, CDKN1A, GADD45A, SESN1) in saliva and blood samples, there was a significant linear association between saliva and blood response of CDKN1A (R2 = 0.60, P = 0.0004). However, the GE pattern of other genes differed between saliva and blood. In summary, the current human in vivo study, (I) reveals significant radiation-induced GE associations of five transcriptional biomarkers in salivary samples, (II) suggests genes predicting diverse clinical outcomes such as acute and late radiotoxicity as well as ARS severity, and (III) supports the view that blood-based GE response can be reflected in saliva samples, indicating that saliva is a “mirror of the body” for certain but not all genes and, thus, studies for each gene of interest in blood are required for saliva.

Developing point of care and high-throughput biological assays for determining absorbed radiation dose

Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry

Toward the development of transcriptional biodosimetry for the identification of irradiated individuals and assessment of absorbed radiation dose

Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate

Rapid High-Throughput Diagnostic Triage after a Mass Radiation Exposure Event Using Early Gene Expression Changes

Experimental Studies on Radiation-induced Expression Changes of Genes Related to Cell Cycle Control and DNA Damage Response

Identification Of The Differentially Expressed Protein Biomarkers In Rat Blood Plasma In Response To Gamma Irradiation

Gene expression signatures that predict radiation exposure in mice and humans

Microfluidic Measurement of Intracellular mRNA with a Molecular Beacon Probe towards Point-of-Care Radiation Triage

Long-Term, Non-Invasive Detection of Low-Dose Ionizing Radiation Exposure

Validation of a blood biomarker panel for machine learning-based radiation biodosimetry in juvenile and adult C57BL/6 mice

Radiation-Induced Changes in Expression of Genes Related to DNA Damage Response in Lymphocytes of Human Peripheral Blood

Positive Cofactor 4 As a Potential Radiation Biodosimeter for Early Assessment

Development of a Point-of-Care Microfluidic RNA Extraction Slide for Gene Expression Diagnosis after Irradiation

Biomarkers for Radiation Biodosimetry and Correlation with Hematopoietic Injury in a Humanized Mouse Model

Transcriptional investigation of biomarkers for late radiation-induced lung toxicity in mice

Characterizing the Immune Cell Transcriptomic Response To Low-Dose Ionizing Radiation

Applicability of Gene Expression in Saliva as an Alternative to Blood for Biodosimetry and Prediction of Radiation-induced Health Effects

Discovering the Radiation Biomarkers in the Plasma of Total-Body Irradiated Leukemia Patients

Interlaboratory comparison of high-throughput protein biomarker assay quantifications for radiation exposure classification

Comparative Analysis of miRNA Expression after Whole-Body Irradiation Across Three Strains of Mice